00:00
2811
C. difficile key opinion leader Erik. R. Dubberke, MD, MSPS speaks about the clinical and economic implications of the disease. Topics discussed include assessing attributable outcomes, C. difficile attributable outcomes (Costs, Morbidity, and Mortality), epidemic strain and outcomes, and laboratory role to improve outcomes.